Key result
Admission hyperglycemia predicts in-hospital major cardiovascular events in elderly STEMI patients undergoing primary PCI.
Why the study?
Admission hyperglycemia in acute myocardial infarction is related to increased in-hospital and long term mortality and major cardiac adverse events, but its impact in elderly STEMI patients after primary PCI needed investigation.
Does high admission blood glucose increase mortality and major adverse cardiac events in elderly patients with STEMI treated by primary PCI?
Cohort (n=677)
Does high admission blood glucose increase mortality and major adverse cardiac events in elderly patients with STEMI treated by primary PCI?
Admission hyperglycemia is an independent predictor of in-hospital major adverse cardiac events and mortality in elderly STEMI patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
May support glucose for risk stratification in elderly STEMI; leaves open whether targeting it improves in-hospital outcomes.
OBJECTIVE: Admission hyperglycemia in acute myocardial infarction (MI) is related with increased in-hospital and long term mortality and major cardiac adverse events. We aimed to investigate how admission hyperglycemia affects the short and long term outcomes in elderly patients (> 65 years) after primary percutaneous coronary intervention for ST elevation myocardial infarction. METHODS: We retrospectively analyzed 677 consecutive elderly patients (mean age 72.2 ± 5.4). Patients were divided into two groups according to admission blood glucose levels. Group 1: low glucose group (LLG), glucose < 168 mg/dL; and Group 2: high glucose group (HGG), glucose > 168 mg/dL. RESULTS: In-hospital, long term mortality and in-hospital major adverse cardiac events were higher in the high admission blood glucose group (P < 0.001). Multivariate regression analysis showed: Killip > 1, post-thrombolysis in MI < 3 and admission blood glucose levels were independent predictors of in-hospital adverse cardiac events (P < 0.001). CONCLUSIONS: Admission hyperglycemia in elderly patients presented with ST elevation myocardial infarction is an independent predictor of in-hospital major adverse cardiac events and is associated with in-hospital and long term mortality.
No takes yet. Share an insight, caveat, or question.
Ekmekçi et al. (2013) conducted a cohort in ST elevation myocardial infarction (n=677). Admission hyperglycemia (blood glucose > 168 mg/dL) vs. Low glucose group (blood glucose < 168 mg/dL) was evaluated on In-hospital major adverse cardiac events and in-hospital and long term mortality (p=< 0.001). Admission hyperglycemia in elderly patients with STEMI undergoing primary PCI was an independent predictor of in-hospital major adverse cardiac events.
Synapse has enriched 10 related papers. Consider them for comparative context: